Compounds > arsenic trioxide
Page last updated: 2024-08-21

arsenic trioxide and Leukemia, T-Cell

arsenic trioxide has been researched along with Leukemia, T-Cell in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nocuń, M; Roszak, J; Smok-Pieniążek, A; Stępnik, M1
Kneifel, C; Lösler, S; Rojewski, MT; Schlief, S; Schrezenmeier, H; Thiel, E1
Baccarani, M; Billi, AM; Bortul, R; Evangelisti, C; Grafone, T; Martelli, AM; Martinelli, G; Tabellini, G; Tazzari, PL1
Jin, J; Liu, J; Ni, W; Qian, W; Xu, W1
Chopin, M; Dombret, H; Pierron, G; Poupon, J; Raffoux, E; Récher, C; Sigaux, F; Stern, MH1

Other Studies

5 other study(ies) available for arsenic trioxide and Leukemia, T-Cell

ArticleYear
Characterization of arsenic trioxide resistant clones derived from Jurkat leukemia T cell line: focus on PI3K/Akt signaling pathway.
    Chemico-biological interactions, 2013, Oct-05, Volume: 205, Issue:3

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Survival; Clone Cells; Flow Cytometry; Gene Expression Profiling; Humans; Jurkat Cells; Leukemia, T-Cell; Oxides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Signal Transduction

2013
Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
    Annals of hematology, 2009, Volume: 88, Issue:11

    Topics: Antimony; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Caspase Inhibitors; Caspases; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Glutathione; HL-60 Cells; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, T-Cell; Membrane Potential, Mitochondrial; Neoplasm Proteins; Oxidation-Reduction; Oxides

2009
Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias.
    British journal of haematology, 2005, Volume: 130, Issue:5

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Line, Tumor; Flow Cytometry; Humans; In Situ Nick-End Labeling; Jurkat Cells; Leukemia; Leukemia, Promyelocytic, Acute; Leukemia, T-Cell; Oxides; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; RNA, Small Interfering; Signal Transduction; Transfection; Tumor Cells, Cultured

2005
Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1.
    Leukemia research, 2007, Volume: 31, Issue:3

    Topics: Apoptosis Regulatory Proteins; Arsenic Trioxide; Arsenicals; Beclin-1; Cell Death; Cell Line, Tumor; Cell Proliferation; Humans; Leukemia, T-Cell; Membrane Proteins; Myelodysplastic Syndromes; Oxides; Phosphorylation; Proto-Oncogene Proteins c-akt; Structure-Activity Relationship; Up-Regulation

2007
In vitro and in vivo effectiveness of arsenic trioxide against murine T-cell prolymphocytic leukaemia.
    British journal of haematology, 2002, Volume: 117, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Leukemia, Prolymphocytic; Leukemia, T-Cell; Male; Mice; Mice, Transgenic; Models, Animal; Oxides; Proto-Oncogene Proteins; Survival Rate; Tumor Cells, Cultured

2002